Filter
253
Text search:
inactivated
vaccines
Featured
Recommendations
24
New Publications
73
Language
Document type
No document type
116
Guidelines
66
Studies & Reports
28
Fact sheets
17
Manuals
13
Strategic & Response Plan
6
Situation Updates
5
Training Material
1
Resource Platforms
1
Countries / Regions
Global
10
Pakistan
8
India
7
Sierra Leone
6
Nigeria
6
Philippines
6
South Africa
6
Afghanistan
5
Tanzania
5
Latin America and the Carribbean
5
Syria
4
Kenya
4
Ukraine
4
Chile
4
Ethiopia
3
Uganda
3
Nepal
3
Germany
3
Africa
3
Liberia
2
Congo, Democratic Republic of
2
Namibia
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Venezuela
2
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
China
1
Rwanda
1
Bangladesh
1
Malawi
1
Papua New Guinea
1
Argentina
1
Peru
1
Brazil
1
Colombia
1
Ecuador
1
Botswana
1
Bolivia
1
Libya
1
Yemen
1
West and Central Africa
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
38
Women & Child Health
12
Public Health
5
Pharmacy & Technologies
4
Key Resources
3
Capacity Building
1
Toolboxes
COVID-19
67
Polio
29
Rapid Response
16
Ebola
13
NTDs
10
TB
9
Pharmacy
9
HIV
8
Cholera
6
Conflict
6
Refugee
5
Zika
4
Planetary Health
3
Natural Hazards
2
Mental Health
2
AMR
2
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedn
...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, prepared
...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strateg
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
WHO Vaccine Management Handbook
This module introduces the “Vaccinator’s Manual”, a guideline for vaccinators. The aim of the manual is to update EPI guidelines to include all the changes since the third edition of the Vaccinators Manual (2008)
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related
...
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to financ
...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to th
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health
...
